ANALYSIS OF GEFITINIB ON BRAIN METASTASES IN PATIENTS WITH NON-SMALL LUNG CANCER

被引：0
|
作者：
Baihao, H. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Resp Dept, Shanghai Chest Hosp, Sch Med, Shanghai 200030, Peoples R China
来源：
RESPIROLOGY | 2011年 / 16卷
关键词：
Non-small cell lung cancer Brain metastases; Gefitinzib;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [21] Gefitinib in patients with brain metastases from non-small-cell lung cancer:: a prospective trial
    Ceresoli, GL
    Cappuzzo, F
    Gregorc, V
    Bartolini, S
    Crinó, L
    Villa, E
    ANNALS OF ONCOLOGY, 2004, 15 (07) : 1042 - 1047
  • [22] Cost Analysis of Brain Metastases Management in Patients with Stage III Non-small Cell Lung Cancer
    Champ, C. E.
    Ohri, N.
    Werner-Wasik, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S571 - S571
  • [23] Effect of endostar combined with gefitinib on multiple brain metastases of non-small cell lung cancer after whole brain radiotherapy
    Li, Maojiang
    Sun, Xiaoxiao
    Dong, Jigang
    Qi, Ying
    Zhao, Yongli
    Guan, Leilei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (01): : 618 - 624
  • [24] Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non-small cell lung cancer (NSCLC) with brain metastases
    Shriyan, Bharati
    Patil, Deepali
    Gurjar, Murari
    Nookala, Manjunath
    Patil, Anand
    Kannan, Sadhana
    Patil, Vijay
    Joshi, Amit
    Noronha, Vanita
    Prabhash, Kumar
    Gota, Vikram
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (10) : 1427 - 1436
  • [25] Gefitinib for Non-Small Cell Lung Cancer Patients with Liver Cirrhosis
    Kim, Young Hak
    Mio, Tadashi
    Mishima, Michiaki
    INTERNAL MEDICINE, 2009, 48 (18) : 1677 - 1679
  • [26] Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non-Small Cell Lung Cancer
    Cagney, Daniel N.
    Martin, Allison M.
    Catalano, Paul J.
    Brown, Paul D.
    Alexander, Brian M.
    Lin, Nancy U.
    Aizer, Ayal A.
    JAMA ONCOLOGY, 2018, 4 (07) : 1001 - 1003
  • [27] Analysis of the response and toxicity to gefitinib of non-small cell lung cancer
    Konishi, J
    Yamazaki, K
    Kinoshita, I
    Isobe, H
    Ogura, S
    Sekine, S
    Ishida, T
    Takashima, R
    Nakadate, M
    Nishikawa, S
    Hattori, T
    Asahina, H
    Imura, M
    Kikuchi, E
    Kikuchi, J
    Shinagawa, N
    Yokouchi, H
    Munakata, M
    Dosaka-Akita, H
    Nishimura, M
    ANTICANCER RESEARCH, 2005, 25 (1B) : 435 - 441
  • [28] Treatment results for non-small cell lung cancer patients presenting with brain metastases
    Shapiro, A.
    Gay, H. A.
    Hahn, S. S.
    Bogart, J. A.
    Shah, H.
    Chung, C. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S512 - S513
  • [29] Survival prediction with radiomics of patients with brain metastases of non-small cell lung cancer
    Prezado, Y.
    Dos Santos, M.
    Gonzalez, W.
    Jouvion, G.
    Guardiola, C.
    Heinrich, S.
    Labiod, D.
    Juchaux, M.
    Jourdain, L.
    Sebrie, C.
    Pouzoulet, F.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S298 - S299
  • [30] Survival in Patients with Non-small Cell Lung Cancer and Brain Metastases and QUARTZ in Practice
    Bradley, K. L.
    Lwin, M. T.
    Laurence, V. M.
    CLINICAL ONCOLOGY, 2010, 22 (10) : 892 - 892
12345